Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Epistemonikos ID: 76175d749126eb6971fb2fa390a464776469e35b
First added on: May 15, 2024